Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Jessica Milner is special counsel in the New York office. In her practice, she evaluates intellectual property issues and provides advice to entrepreneurs, investors, and emerging and established companies on the development and commercialization of technologies in a wide range of industries. Ms. Milner has specific experience counseling pharmaceutical and biotechnology companies in connection with licensing, collaboration, and other strategic arrangements. She also regularly conducts due diligence assessments and advises on the intellectual property aspects of mergers, acquisitions, corporate financings and other business transactions. Ms. Milner maintains a commitment to public service and to strengthening New York City as a center of entrepreneurship.

Ms. Milner is a patent attorney registered with the United States Patent and Trademark Office.

  • AstraZeneca in its licensing arrangement with LEO Pharma for the development and commercialization of the antibody tralokinimab for atopic dermatitis and other skin diseases, which arrangement provided for an up-front payment of $115 million and additional milestones of up to $1 billion.
  • An early-stage biotechnology company in securing from a large, public university an exclusive license to genetic engineering technology.
  • Regeneron Pharmaceuticals, Inc. in its global collaboration with Sanofi to develop novel antibody-based immuno-oncology treatments.
  • Illumina, Inc. in its acquisition of Verinata Health, Inc. for cash consideration of $350 million plus up to $100 million in milestone payments through 2015.   
  • Thomson Reuters Corporation in the divestiture of its Healthcare business to affiliates of Veritas Capital for $1.25 billion in cash.
  • Bristol-Myers Squibb Company in its all-cash acquisition of Amira Pharmaceuticals, Inc. for $325 million upfront and potential additional milestone payments totaling $150 million.
  • National Geographic Society in the sale of its Hampton Brown school publishing business to Cengage Learning, Inc.
  • An emerging biotechnology company in private placements of over $27 million in senior convertible notes and warrants and in a $22 million Series A preferred stock financing.
  • A technology-based early-stage company in developing its key commercial agreements.
  • Various pharmaceutical companies on the listing of patents in the Food and Drug Administration's “Orange Book” and in complying with the requirements of the Bayh-Dole Act.

Pro Bono

  • Prepared website terms of use and privacy policy for a socially conscious job-search website start-up company.
  • Drafted database system intellectual property assignment and license agreement for a non-profit corporation dedicated to the support and guidance of aging-in-place initiatives.
  • Empire State Counsel Honoree, New York State Bar Association (2008-2015)

Memberships and Affiliations

  • Served as a long-term member of the board of directors of Coalition for Queens, a not-for-profit corporation fostering a tech entrepreneurial ecosystem in the borough of Queens in New York City through education, advocacy, and partnerships.

Previous Experience

  • Harvard Legal Aid Bureau, Student Attorney (2004-2006)
  • New York Super Lawyers, Intellectual Property "Rising Star" (2013, 2014, 2015, 2016, 2017)